US Patent 7285533 Apo-2 ligand
Patent 7285533 was granted and assigned to Genentech on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+438 characters)
Article
Patent abstract
A novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided. The Apo-2 ligand is believed to be a member of the TNF cytokine family. Compositions including Apo-2 ligand chimeras, nucleic acid encoding Apo-2 ligand, and antibodies to Apo-2 ligand are also provided. Methods of using Apo-2 ligand to induce apoptosis and to treat pathological conditions such as cancer, are further provided.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07285533 Apo-2 ligand US Patent 7285533 Apo-2 ligand
Infobox
Patent Number
0728553300
Patent Number
728553300
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072855330
Date of Patent
October 23, 2007
0Patent Application Number
108616850
Date Filed
June 4, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072855330
Date of Patent
October 23, 2007
0Patent Application Number
108616850
Date Filed
June 4, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07285533 Apo-2 ligand
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07285533
Date of patent
October 23, 2007
Patent application number
10861685
Date Filed
June 4, 2004
Patent primary examiner
Find more entities like US Patent 7285533 Apo-2 ligand
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
